The GMR Clinical Trials Unit has liver clinical trials recruiting. Protocol: BIO89-100-131 (PI: DR DARRELL CRAWFORD) - CURRENTLY RECRUITING Protocol Title: A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Metabolic Dysfunction-Associated Steatohepatitis (MASH) and...
The GMR Clinical Trials Unit is currently recruiting for the following clinical trials in general oncology: PROTOCOL: V940-007 (pi: dR D. Rahul Ladwa) Protocol Title: A Phase 2/3, adaptive, randomized, open-label, clinical study to evaluate neoadjuvant and adjuvant V940 (mRNA-4157) in combination...
Currently recruiting gastro-intestinal trials Protocol: AMT-676-01 (PI: DR Warren Joubert) Protocol Title: First-in-Human, Phase 1 Study of AMT-676, an Anti CDH17 Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors Click here for more information Protocol: AMP945-PC-201 (PI:...
The GMR Clinical Trials Unit will soon be recruiting for the following lung clinical trial: Protocol: ca224-1093 (PI: Dr kenneth o'byrne) Protocol Title: A Phase 3, Randomized, Open-label Study of Nivolumab + Relatlimab Fixed-dose Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy...
The GMRF Clinical Trials Unit is currently recruiting for the following melanoma trials: PROTOCOL: IMC-F106C-301 (PI: Professor Victoria Atkinson) Protocol Title: A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants...
The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in genitourinary cancer: Protocol: MK-5684-01A (PI: Dr Jeffrey GOH) Protocol Title: MK-5684-01A Substudy: A Phase 1/2 Umbrella Substudy of MK-5684-U01 Master Protocol to Evaluate the Safety and Efficacy of MK-5684-Based...
The GMR Clinical Trials Unit is not currently recruiting any clinical trials in Haematology.
The GMR Clinical Trials Unit is currently recruiting for the following clinical trials in respiratory illness: protocol: mkc-ci-002 (PI: dr rachel thomson) (not yet recruiting) Protocol Title: ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Clofazimine...
There are no studies currently recruiting for infectious diseases